Oct 16, 2025
HBVtech has been awarded a number of grants locally and nationally.
Aug 27, 2025. HBVtech was awarded an NIH R34 grant to support HBVZ10 IND planning project.
July 28, 2025. HBVtech was awarded an NIH SBIR research contract on topic 137 titled “ New Drug Classes with Novel Mechanisms of Action for HIV, Hepatitis B, and Tuberculosis”. This award includes both phase I (base) and II (option) for 5 years.
June 26, 2025. HBVtech was awarded a Technology/Therapeutic Development Award (TTDA), part of Congressionally Directed Medical Research Programs (CDMRP), managed by DoD. This award covers 4 years to advance HBVZ10 IND studies.
May 30, 2025. HBVtech was awarded a Montgomery County Technology Innovation Grant to support two HBVtech PCT applications and prosecution in 8 countries and regions.